Cytokines in the pathogenesis of atherosclerosis
JL Young, P Libby, U Schönbeck - Thrombosis and …, 2002 - thieme-connect.com
Research during the last two decades established atheromatous lesions as active sites of
inflammation and immune responses, contrasting to the traditional view of atherosclerosis as …
inflammation and immune responses, contrasting to the traditional view of atherosclerosis as …
Cytokines in atherosclerosis: pathogenic and regulatory pathways
A Tedgui, Z Mallat - Physiological reviews, 2006 - journals.physiology.org
Atherosclerosis is a chronic disease of the arterial wall where both innate and adaptive
immunoinflammatory mechanisms are involved. Inflammation is central at all stages of …
immunoinflammatory mechanisms are involved. Inflammation is central at all stages of …
Interleukins in atherosclerosis: molecular pathways and therapeutic potential
JH Von der Thüsen, J Kuiper, TJC Van Berkel… - Pharmacological …, 2003 - ASPET
Interleukins are considered to be key players in the chronic vascular inflammatory response
that is typical of atherosclerosis. Thus, the expression of proinflammatory interleukins and …
that is typical of atherosclerosis. Thus, the expression of proinflammatory interleukins and …
[HTML][HTML] Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most
deaths in westernized societies with numbers increasing at a marked rate in developing …
deaths in westernized societies with numbers increasing at a marked rate in developing …
Macrophages and immune cells in atherosclerosis: recent advances and novel concepts
C Cochain, A Zernecke - Basic research in cardiology, 2015 - Springer
Atherosclerotic lesion-related thrombosis is the major cause of myocardial infarction and
stroke, which together constitute the leading cause of mortality worldwide. The inflammatory …
stroke, which together constitute the leading cause of mortality worldwide. The inflammatory …
Role of inflammatory cytokines in genesis and treatment of atherosclerosis
Atherosclerosis demonstrates an increased rate of vascular smooth muscle cells (VSMC)
plasticity characterized by switching from the differentiated contractile phenotype to a de …
plasticity characterized by switching from the differentiated contractile phenotype to a de …
Interferon-γ and atherosclerosis: pro-or anti-atherogenic?
EJ Harvey, DP Ramji - Cardiovascular research, 2005 - academic.oup.com
Atherosclerosis is considered to be a form of chronic inflammation governed by a complex
network of inter-and intra-cellular signaling pathways. The pleiotropic cytokine interferon-γ …
network of inter-and intra-cellular signaling pathways. The pleiotropic cytokine interferon-γ …
Macrophages in vascular inflammation and atherosclerosis
C Cochain, A Zernecke - Pflügers Archiv-European Journal of Physiology, 2017 - Springer
Atherosclerosis is characterized by lipid accumulation and chronic inflammation of the
arterial wall, and its main complications—myocardial infarction and ischemic stroke …
arterial wall, and its main complications—myocardial infarction and ischemic stroke …
Atherosclerosis and immunity: a perspective
F Abdolmaleki, SMG Hayat, V Bianconi… - Trends in cardiovascular …, 2019 - Elsevier
Atherosclerosis is an inflammatory and multifaceted disorder resulting from the accumulation
of lipid droplets and several types of immune cells, including macrophages, T and B …
of lipid droplets and several types of immune cells, including macrophages, T and B …
Atherosclerosis and interferon-γ: new insights and therapeutic targets
I Voloshyna, MJ Littlefield, AB Reiss - Trends in cardiovascular medicine, 2014 - Elsevier
Atherosclerosis is considered to be a chronic inflammatory disease of the arterial wall.
Atherogenesis is accompanied by local production and release of inflammatory mediators …
Atherogenesis is accompanied by local production and release of inflammatory mediators …